Abstracts Archive - Page 549 of 1683 - ATC Abstracts

2020 American Transplant Congress
Altruistic Liver Donors at Thomas E Starzl Transplant Institute: Impact of the Educational Campaign: Gift of Life
S. Ganesh, M. Molinari, L. Tubb, A. Tevar, C. Hughes, J. Behari, A. Humar
Transplant Surgery, UPMC Thomas E Starzl Transplant Institute, Pittsburgh, PA
*Purpose: Background and aims: There is an urgent need to expand access to living donor liver transplants due to a wide gap in the availability…
2020 American Transplant Congress
Health-Related Quality of Life after Anonymous Nondirected Living Liver Donation: A Multi-Center, North American Collaboration
M. H. Raza¹, W. E. Jackson², A. Dell³, L. Ding⁴, J. Shapiro³, E. A. Pomfret⁵, Y. Genyk⁶, L. Sher⁶, J. Emamaullee⁶
¹Keck School of Medicine of USC, Los Angeles, CA, ²Gastroenterology, University of Colorado, Aurora, CO, ³Surgery, University of Alberta, Edmonton, AB, Canada, ⁴Preventive Medicine, University of Southern California, Los Angeles, CA, ⁵Surgery, University of Colorado, Aurora, CO, ⁶Surgery, University of Southern California, Los Angeles, CA
*Purpose: Literature on anonymous or ‘altruistic’ nondirected living liver donors (ND-LLDs) remains sparse as living donor liver transplant (LDLT) programs continue to explore the utilization…
2020 American Transplant Congress
The Impact of Non-Directed Anonymous Live Liver Donors on the Number of Children on the Waitlist at a Single Pediatric Liver Transplant Center
D. Yoeli¹, M. A. Adams¹, M. E. Wachs¹, S. S. Sundaram², R. A. Choudhury¹, K. D. Conzen¹, J. R. Burton³, E. A. Pomfret¹, W. E. Jackson³
¹Transplant Surgery, University of Colorado, Aurora, CO, ²Pediatric Hepatology, University of Colorado, Aurora, CO, ³Transplant Hepatology, University of Colorado, Aurora, CO
*Purpose: Since the initiation of our living donor (LD) pediatric liver transplant program in November 2016, 10 non-directed anonymous donors have been approved and completed…
2020 American Transplant Congress
Adult Living Donor Liver Transplantation Results in Superior Patient and Graft Survival When Compared to Deceased Donor Liver Transplantation: A Systematic Review and Meta-Analysis
A. Barbetta¹, M. Aljehani², M. KIM¹, C. Tien³, A. Ahearn¹, H. Schilperoort², L. Sher¹, J. Emamaullee¹
¹Surgery, abdominal transplat, University of Southern California, Los Angeles, CA, ²University of Southern California, Los Angeles, CA, ³Surgery, abdominal transplat, Keck Medical School, University of Southern California, Los Angeles, CA
*Purpose: Center-specific or national registry studies have shown that living donor liver transplantation (LDLT) decreases waitlist mortality, reduces waiting time, and may offer superior patient…
2020 American Transplant Congress
Early Outcomes with the Liver-Kidney Safety Net
R. M. Cannon¹, D. S. Goldberg², D. E. Eckhoff¹, D. J. Anderson¹, B. J. Orandi¹, J. E. Locke¹
¹University of Alabama at Birmingham, Birmingham, AL, ²University of Miami, Miami, FL
*Purpose: A safety net policy was implemented in August 2017 giving liver alone recipients with significant renal dysfunction post-transplant priority for subsequent renal transplantation. This…
2020 American Transplant Congress
Incidence of Chronic Kidney Disease after Liver Transplantation Using Measured GFR
N. R. Mazumder¹, J. Levitsky¹, G. Saracino², G. Klintmalm³, J. Trotter², S. Asrani²
¹Gastroenterology and Hepatology, Northwestern University, Chicago, IL, ²Transplant Hepatology, Baylor University Medical Center Dallas, Dallas, TX, ³Transplant Surgery, Baylor University Medical Center Dallas, Dallas, TX
*Purpose: Historical rates of ESRD after LT are 8% (1 year) and 18% (5 years) (Ojo NEJM 2003). However, these rates were based older estimates…
2020 American Transplant Congress
Perioperative Opioid Avoidance in Liver Transplant Recipients: Significant Reduction in Opioid Use Through a Multidiscplinary, Multimodal Approach
H. Kutzler, R. Gannon, W. Nolan, L. Meisterling, M. Cech, D. Gleason, J. Uzl, C. Rochon, B. Maneckshana, O. Serrano, J. Riley, D. O'Sullivan, E. Urtasun-Sotil, M. Einstein, P. Sheiner
Hartford Hospital, Hartford, CT
*Purpose: Given the association between substance use disorder and risk of post-surgical opioid use disorder, we developed an opioid avoidance pathway (OAP) in adult liver…
2020 American Transplant Congress
Liver Retransplantation (reLT) in the Modern Post-MELD, Post-DAA Era
B. Shi, C. Freise, D. Brandman
School of Medicine, UCSF, San Francisco, CA
*Purpose: Liver retransplantation (reLT) is responsible for a small proportion of all liver transplants (LT), but outcomes are much worse than primary LT. Hepatitis C…
2020 American Transplant Congress
Sequential Protocol Biopsies Post-Liver Transplant from Donors with Moderate Macrosteatosis: What Happens to the Fat?
K. Croome, D. Livingston, C. Taner, R. Nakhleh
Mayo Clinic Jacksonville, Jacksonville, FL
*Purpose: The number of steatotic deceased donor livers encountered has continued to rise as a result of the obesity epidemic. Little is known about the…
2020 American Transplant Congress
Safety and Immunogenicity of Adjuvanted Recombinant Subunit Herpes Zoster Vaccine in Lung Transplant Recipients
C. Hirzel¹, V. H. Ferreira¹, A. G. L’Huillier¹, T. Ku¹, M. Ierullo¹, C. Miao², D. S. Schmid², J. Tikkanen¹, L. G. Singer¹, A. Humar¹, D. Kumar¹
¹University Health Network, Toronto, ON, Canada, ²CDC, Atlanta, GA
*Purpose: The new adjuvanted subunit recombinant herpes zoster vaccine (RZV; Shingrix™) may have potential utility in transplant patients for the prevention of shingles, but there…